Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Amneal Pharmaceuticals Inc shares valued at $452,537 were sold by Patel Gautam on Jun 10 ’25. At $8.02 per share, Patel Gautam sold 56,426 shares. The insider’s holdings dropped to 1,704,050 shares worth approximately $13.56 million following the completion of this transaction.
Also, Shah Nikita sold 49,140 shares, netting a total of over 372,481 in proceeds. Following the sale of shares at $7.58 each, the insider now holds 388,929 shares.
Before that, Shah Nikita had added 49,140 shares to its account. In a trade valued at $368,550, the Officer bought Amneal Pharmaceuticals Inc shares for $7.50 each.
As published in their initiating research note from Goldman on June 06, 2025, Amneal Pharmaceuticals Inc [AMRX] has been a Buy and the price target has been revised to $12. Analysts at JP Morgan upgraded the stock from ‘”a Neutral”‘ to ‘”an Overweight”‘ outlook in a report released in late February. As of September 06, 2024, JP Morgan has increased its “an Underweight” rating to a “Neutral” for AMRX.
Analyzing AMRX Stock Performance
On last trading session,, Amneal Pharmaceuticals Inc [NASDAQ: AMRX] rose 2.31% to $7.96. The stock’s lowest price that day was $7.75, but it reached a high of $7.9981 in the same session. During the last five days, there has been a surge of approximately 11.02%. Over the course of the year, Amneal Pharmaceuticals Inc shares have jumped approximately 0.51%.
Support And Resistance Levels for Amneal Pharmaceuticals Inc (AMRX)
RSI (Relative Strength Index) is 63.09 on the 14-day chart, showing neutral technical sentiment.
Is Amneal Pharmaceuticals Inc subject to short interest?
Stocks of Amneal Pharmaceuticals Inc saw a sharp steep in short interest on 2025-05-30 dropping by -1.9 million shares to 4.2 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 6.1 million shares. A decline of -45.12% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.15 of the overall float, the days-to-cover ratio (short ratio) decline to 2.15.
Which companies own the most shares of Amneal Pharmaceuticals Inc (AMRX)?
In terms of Amneal Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 11 in the next 12 months, up nearly 41.39% from the previous closing price of $7.78. Analysts anticipate Amneal Pharmaceuticals Inc stock to reach 11 by 2025, with the lowest price target being 11. In spite of this, 1 analysts ranked Amneal Pharmaceuticals Inc stock as Buy at the end of 2025. On March 08, 2021, Goldman assigned a price target of “a Buy” to the stock and upgraded coverage with a $6.50.
